Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-02-06 Sale | 2026-02-10 7:09 pm | Emergent BioSolutions Inc. | EBS | Glessner Coleen EVP, Quality & Ethics, and CPL | 28,847 | $10.92 | $315,009 | 112,620 (Direct) | View |
| 2026-02-06 Sale | 2026-02-10 7:07 pm | Emergent BioSolutions Inc. | EBS | Williams Paul Anthony SVP, Products Business | 8,655 | $10.92 | $94,513 | 76,194 (Direct) | View |
| 2026-02-06 Sale | 2026-02-10 7:06 pm | Emergent BioSolutions Inc. | EBS | Hartzel William SVP, Bioservices | 5,771 | $10.92 | $63,019 | 96,681 (Direct) | View |
| 2026-02-06 Sale | 2026-02-10 7:06 pm | Emergent BioSolutions Inc. | EBS | LINDAHL RICHARD S EVP, Chief Financial Officer | 46,155 | $10.92 | $504,013 | 239,700 (Direct) | View |
| 2025-12-05 Sale | 2025-12-09 6:01 pm | Emergent BioSolutions Inc. | EBS | Richard Ronald Director | 21,984 | $11.97 | $263,077 | 98,417 (Direct) | View |
| 2025-11-10 Sale | 2025-11-12 4:13 pm | Emergent BioSolutions Inc. | EBS | DeGolyer Donald W Director | 17,801 | $10.54 | $187,623 | 119,858 (Direct) | View |
| 2025-11-07 Sale | 2025-11-10 4:09 pm | Emergent BioSolutions Inc. | EBS | Dayal Sujata Tyagi Director | 8,552 | $10 | $85,520 | 88,980 (Direct) | View |
| 2025-10-07 Sale | 2025-10-16 4:21 pm | Emergent BioSolutions Inc. | EBS | Glessner Coleen EVP, Quality & Ethics, and CPL | 30,608 | $10 | $306,080 | 144,319 (Direct) | View |
| 2025-08-15 Sale | 2025-08-18 4:33 pm | Emergent BioSolutions Inc. | EBS | Zoon Kathryn C Director | 7,086 | $8.87 | $62,853 | 71,799 (Direct) | View |
| 2025-08-12 Sale | 2025-08-13 4:22 pm | Emergent BioSolutions Inc. | EBS | DeGolyer Donald W Director | 7,844 | $8.6475 | $67,831 | 137,659 (Direct) | View |
| 2025-05-23 Sale | 2025-05-28 4:08 pm | Emergent BioSolutions Inc. | EBS | Katkin Keith Director | 7,844 | $6.3 | $49,417 | 86,431 (Direct) | View |
| 2025-05-13 Purchase | 2025-05-15 4:02 pm | Emergent BioSolutions Inc. | EBS | PAPA JOSEPH C President and CEO | 60,000 | $5.83 | $349,800 | 342,500 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-05-07 Expired | 2026-03-06 08:50 am | N/A 2025-05-07 | Emergent BioSolutions Inc. | EBS | LINDAHL RICHARD S EVP, Chief Financial Officer | 40,284 | $0 | 0 (Direct) | View |
| 2026-03-03 Option Award | 2026-03-05 9:40 pm | N/A 2033-03-02 | Emergent BioSolutions Inc. | EBS | PAPA JOSEPH C President and CEO | 252,194 | $0 | 2,090,139 (Direct) | View |
| 2026-03-05 Tax Withholding | 2026-03-05 9:40 pm | N/A N/A | Emergent BioSolutions Inc. | EBS | PAPA JOSEPH C President and CEO | 37,055 | $8.44 | 2,090,139 (Direct) | View |
| 2026-03-03 Option Award | 2026-03-05 9:38 pm | N/A N/A | Emergent BioSolutions Inc. | EBS | FOWLER JOHN D JR Director | 5,006 | $8.99 | 5,006 (Direct) | View |
Ownership | 2026-03-05 9:37 pm | N/A N/A | Emergent BioSolutions Inc. | EBS | FOWLER JOHN D JR Director | 0 | $0 | 0 (Direct) | View |
| 2026-03-03 Option Award | 2026-03-05 9:21 pm | N/A 2033-03-02 | Emergent BioSolutions Inc. | EBS | Lowry Simon C SVP, R&D, CMO | 44,834 | $0 | 225,636 (Direct) | View |
| 2026-03-05 Tax Withholding | 2026-03-05 9:21 pm | N/A N/A | Emergent BioSolutions Inc. | EBS | Lowry Simon C SVP, R&D, CMO | 10,636 | $8.44 | 225,636 (Direct) | View |
| 2026-03-03 Option Award | 2026-03-05 9:20 pm | N/A 2033-03-02 | Emergent BioSolutions Inc. | EBS | Hartzel William SVP, Bioservices | 44,834 | $0 | 346,733 (Direct) | View |
| 2026-03-05 Tax Withholding | 2026-03-05 9:20 pm | N/A N/A | Emergent BioSolutions Inc. | EBS | Hartzel William SVP, Bioservices | 9,493 | $8.44 | 346,733 (Direct) | View |
| 2026-03-03 Option Award | 2026-03-05 9:19 pm | N/A 2033-03-02 | Emergent BioSolutions Inc. | EBS | Perl Jessica SVP, General Counsel, Corp Sec | 46,702 | $0 | 203,651 (Direct) | View |
| 2026-03-05 Tax Withholding | 2026-03-05 9:19 pm | N/A N/A | Emergent BioSolutions Inc. | EBS | Perl Jessica SVP, General Counsel, Corp Sec | 6,465 | $8.44 | 203,651 (Direct) | View |
| 2026-03-03 Option Award | 2026-03-05 9:08 pm | N/A 2033-03-02 | Emergent BioSolutions Inc. | EBS | Williams Paul Anthony SVP, Products Business | 44,834 | $0 | 321,629 (Direct) | View |
| 2026-03-05 Tax Withholding | 2026-03-05 9:08 pm | N/A N/A | Emergent BioSolutions Inc. | EBS | Williams Paul Anthony SVP, Products Business | 9,397 | $8.44 | 321,629 (Direct) | View |
| 2026-03-03 Option Award | 2026-03-05 9:07 pm | N/A 2033-03-02 | Emergent BioSolutions Inc. | EBS | LINDAHL RICHARD S EVP, Chief Financial Officer | 72,856 | $0 | 772,713 (Direct) | View |
| 2026-03-05 Tax Withholding | 2026-03-05 9:07 pm | N/A N/A | Emergent BioSolutions Inc. | EBS | LINDAHL RICHARD S EVP, Chief Financial Officer | 23,650 | $8.44 | 772,713 (Direct) | View |
| 2026-03-03 Option Award | 2026-03-05 9:06 pm | N/A 2033-03-02 | Emergent BioSolutions Inc. | EBS | Glessner Coleen EVP, Quality & Ethics, and CPL | 44,834 | $0 | 398,555 (Direct) | View |
| 2026-03-05 Tax Withholding | 2026-03-05 9:06 pm | N/A N/A | Emergent BioSolutions Inc. | EBS | Glessner Coleen EVP, Quality & Ethics, and CPL | 8,199 | $8.44 | 398,555 (Direct) | View |
| 2026-03-02 Tax Withholding | 2026-03-03 4:33 pm | N/A N/A | Emergent BioSolutions Inc. | EBS | Williams Paul Anthony SVP, Products Business | 116 | $8.15 | 76,078 (Direct) | View |
| 2026-03-02 Tax Withholding | 2026-03-03 4:32 pm | N/A N/A | Emergent BioSolutions Inc. | EBS | LINDAHL RICHARD S EVP, Chief Financial Officer | 683 | $8.15 | 239,017 (Direct) | View |
| 2026-03-02 Tax Withholding | 2026-03-03 4:16 pm | N/A N/A | Emergent BioSolutions Inc. | EBS | Glessner Coleen EVP, Quality & Ethics, and CPL | 313 | $8.15 | 112,307 (Direct) | View |
| 2026-02-09 Tax Withholding | 2026-02-10 7:11 pm | N/A N/A | Emergent BioSolutions Inc. | EBS | Perl Jessica SVP, General Counsel, Corp Sec | 918 | $11.03 | 67,469 (Direct) | View |
| 2026-02-06 Tax Withholding | 2026-02-10 7:09 pm | N/A N/A | Emergent BioSolutions Inc. | EBS | Glessner Coleen EVP, Quality & Ethics, and CPL | 2,852 | $10.92 | 112,620 (Direct) | View |
| 2026-02-06 Tax Withholding | 2026-02-10 7:07 pm | N/A N/A | Emergent BioSolutions Inc. | EBS | Williams Paul Anthony SVP, Products Business | 1,022 | $10.92 | 76,194 (Direct) | View |
| 2026-02-06 Tax Withholding | 2026-02-10 7:06 pm | N/A N/A | Emergent BioSolutions Inc. | EBS | Hartzel William SVP, Bioservices | 630 | $10.92 | 96,681 (Direct) | View |
| 2026-02-06 Tax Withholding | 2026-02-10 7:06 pm | N/A N/A | Emergent BioSolutions Inc. | EBS | LINDAHL RICHARD S EVP, Chief Financial Officer | 5,642 | $10.92 | 239,700 (Direct) | View |
| 2025-12-15 Tax Withholding | 2025-12-16 4:12 pm | N/A N/A | Emergent BioSolutions Inc. | EBS | Lowry Simon C SVP, R&D, CMO | 3,543 | $11.41 | 88,439 (Direct) | View |
| 2025-12-05 Tax Withholding | 2025-12-09 6:01 pm | N/A N/A | Emergent BioSolutions Inc. | EBS | Richard Ronald Director | 10,864 | $11.9 | 98,417 (Direct) | View |
| 2025-12-05 Exercise | 2025-12-09 6:01 pm | N/A N/A | Emergent BioSolutions Inc. | EBS | Richard Ronald Director | 25,748 | $5.02 | 98,417 (Direct) | View |
| 2025-12-05 Exercise | 2025-12-09 6:01 pm | N/A 2031-05-22 | Emergent BioSolutions Inc. | EBS | Richard Ronald Director | 25,748 | $0 | 98,417 (Direct) | View |
| 2025-11-11 Tax Withholding | 2025-11-13 4:01 pm | N/A N/A | Emergent BioSolutions Inc. | EBS | Hartzel William SVP, Bioservices | 610 | $10.88 | 103,082 (Direct) | View |
| 2025-10-15 Tax Withholding | 2025-10-17 4:02 pm | N/A N/A | Emergent BioSolutions Inc. | EBS | LINDAHL RICHARD S EVP, Chief Financial Officer | 4,995 | $9.6 | 291,497 (Direct) | View |
| 2025-07-11 Tax Withholding | 2025-07-15 4:04 pm | N/A N/A | Emergent BioSolutions Inc. | EBS | Hartzel William SVP, Bioservices | 4,263 | $7.36 | 103,692 (Direct) | View |
| 2025-06-08 Tax Withholding | 2025-06-10 4:12 pm | N/A N/A | Emergent BioSolutions Inc. | EBS | Hartzel William SVP, Bioservices | 1,167 | $6.63 | 107,955 (Direct) | View |
| 2025-06-08 Tax Withholding | 2025-06-10 4:12 pm | N/A N/A | Emergent BioSolutions Inc. | EBS | Glessner Coleen EVP, Quality & Ethics, and CPL | 1,249 | $6.63 | 174,927 (Direct) | View |
| 2025-06-08 Tax Withholding | 2025-06-10 4:12 pm | N/A N/A | Emergent BioSolutions Inc. | EBS | Williams Paul Anthony SVP, Products Business | 464 | $6.63 | 85,871 (Direct) | View |
| 2025-06-08 Tax Withholding | 2025-06-10 4:07 pm | N/A N/A | Emergent BioSolutions Inc. | EBS | LINDAHL RICHARD S EVP, Chief Financial Officer | 2,733 | $6.63 | 296,492 (Direct) | View |
| 2025-04-30 Option Award | 2025-05-02 8:31 pm | N/A 2032-04-29 | Emergent BioSolutions Inc. | EBS | Richard Ronald Director | 50,227 | $0 | 147,089 (Direct) | View |
| 2025-04-30 Option Award | 2025-05-02 8:31 pm | N/A 2032-04-29 | Emergent BioSolutions Inc. | EBS | White Marvin L Director | 50,227 | $0 | 130,067 (Direct) | View |
| 2025-04-30 Option Award | 2025-05-02 8:31 pm | N/A 2032-04-29 | Emergent BioSolutions Inc. | EBS | Fowler Neal Franklin Director | 50,227 | $0 | 177,075 (Direct) | View |
| 2025-04-30 Option Award | 2025-05-02 8:31 pm | N/A 2032-04-29 | Emergent BioSolutions Inc. | EBS | Zoon Kathryn C Director | 50,227 | $0 | 120,457 (Direct) | View |
| 2025-04-30 Option Award | 2025-05-02 8:31 pm | N/A 2032-04-29 | Emergent BioSolutions Inc. | EBS | Dayal Sujata Tyagi Director | 50,227 | $0 | 139,104 (Direct) | View |
| 2025-04-30 Option Award | 2025-05-02 8:30 pm | N/A 2032-04-29 | Emergent BioSolutions Inc. | EBS | Katkin Keith Director | 50,227 | $0 | 135,847 (Direct) | View |